![Brian Lynch](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Brian Lynch
Net worth: 933 213 $ as of 2024-06-29
Network origin in Brian Lynch first degree
Entity | Entity type | Industry | |
---|---|---|---|
Public Company | Pharmaceuticals: Major | 18 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Brian Lynch via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
University of Maryland | College/University | Undergraduate Degree Undergraduate Degree Doctorate Degree | |
KPMG LLP
![]() KPMG LLP Miscellaneous Commercial ServicesCommercial Services KPMG LLP engages in the provision of audit, tax, and advisory services. It serves the banking and capital markets, building, construction and real estate, consumer and retail, energy, natural resources and chemicals, financial services, government and public sector, healthcare and life sciences, industrial manufacturing, insurance, media and entertainment, private equity, technology, telecommunications, and venture capital industries. The company was founded in 1987 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
AKCEA THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Operating Officer Corporate Officer/Principal | |
Princeton University | College/University | Undergraduate Degree Undergraduate Degree | |
AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
ACADIA PHARMACEUTICALS INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
INCYTE CORPORATION | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
Amgen Ventures LLC
![]() Amgen Ventures LLC Investment ManagersFinance Amgen Ventures LLC (Amgen Ventures) is a venture capital firm, a subsidiary of Amgen, Inc. founded in 2004. The firm is headquartered in Thousand Oaks, California. | Investment Managers | Corporate Officer/Principal | |
HALOZYME THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
BELLICUM PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member | |
ARGENX SE | Pharmaceuticals: Other | Director/Board Member | |
Vicuron Pharmaceuticals LLC
![]() Vicuron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Vicuron Pharmaceuticals LLC develops pharmaceutical products. It engages in discovering, developing, manufacturing, and commercializing vital medicine for seriously ill patients. The company offers anidulafungin drug, which prevents cell wall formation and other infectious fungi. It also offers antibiotic for the treatment of complicated skin and soft-tissue infections. The company was founded by Christopher T. Walsh in 1995 and is headquartered in King of Prussia, PA. | Pharmaceuticals: Major | Director/Board Member | |
COHERUS BIOSCIENCES, INC. | Pharmaceuticals: Major | Director/Board Member | |
The Colorado College
![]() The Colorado College Other Consumer ServicesConsumer Services Colorado College provide a broad liberal arts education to students. The college was founded in May 6, 1874 and it is headquartered in Colorado Springs, CO | College/University | Undergraduate Degree | |
NEUBASE THERAPEUTICS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Ariana Pharmaceuticals SA
![]() Ariana Pharmaceuticals SA Pharmaceuticals: MajorHealth Technology Ariana Pharmaceuticals SA provides pharmaceutical, clinical and data technology. It offers analytics for multi-paramedic data in identifying patient responders to reduce clinical and drug development risk. The firm also develops biomarker signatures to develop processes in anawlyzing multi-paramedic data. The company was founded by Mohammad Afshar in 2003 and is headquartered in Paris, France. | Pharmaceuticals: Major | Director/Board Member | |
EMD Serono, Inc.
![]() EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
University of California, Los Angeles | College/University | Doctorate Degree | |
CHIMERIX, INC. | Pharmaceuticals: Major | Director/Board Member | |
State University of New York at Buffalo | College/University | Masters Business Admin | |
GlaxoSmithKline LLC
![]() GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Francis Cauffman, Inc.
![]() Francis Cauffman, Inc. Engineering & ConstructionIndustrial Services Francis Cauffman, Inc. provides architecture, interior design, and planning services. The firm specializes in healthcare, science & technology and corporate. The company was founded by Hughes D. Cauffman, James Francis and George Wikinson in 1954 and is headquartered in New York, NY. | Engineering & Construction | Corporate Officer/Principal | |
True North Therapeutics, Inc.
![]() True North Therapeutics, Inc. BiotechnologyHealth Technology True North Therapeutics, Inc. operates as a biopharmaceutical company. It focuses on the discovery, development, and commercialization of first-in-class product candidates for complement-mediated diseases. The company was founded by Nancy E. Stagliano in 2013 and is headquartered in South San Francisco, CA. | Biotechnology | Chief Executive Officer | |
Bioverativ Therapeutics, Inc.
![]() Bioverativ Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Bioverativ Therapeutics, Inc. develops pharmaceutical products. It develops medicines for chronic diseases such as hemophilia, anemia, multiple sclerosis, and autoimmune disorders. The company is headquartered in Cambridge, MA. | Pharmaceuticals: Major | President | |
Harvard Business School | College/University | Masters Business Admin | |
Biotechnology Innovation Organization
![]() Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member | |
SANOFI | Pharmaceuticals: Major | Corporate Officer/Principal | |
BIOVERATIV INC | Biotechnology | President | |
Genzyme Corp.
![]() Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | President | |
AVANIR PHARMACEUTICALS INC | Pharmaceuticals: Major | Corporate Officer/Principal | |
DYAX CORP. | Pharmaceuticals: Major | Corporate Officer/Principal | |
ActivX Biosciences, Inc.
![]() ActivX Biosciences, Inc. Pharmaceuticals: MajorHealth Technology ActivX Biosciences, Inc. develops pharmaceutical products. It discovers and develops small molecule drugs for major unmet medical needs. The company was founded in 2000 and is located in La Jolla, CA | Pharmaceuticals: Major | Corporate Officer/Principal | |
Genfit Corp. | Corporate Officer/Principal | ||
Duke University
![]() Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Undergraduate Degree | |
MODERNA, INC. | Biotechnology | Corporate Officer/Principal | |
Thomas Jefferson University | College/University | Undergraduate Degree | |
Takeda California, Inc.
![]() Takeda California, Inc. Pharmaceuticals: MajorHealth Technology Takeda California, Inc. is a pharmaceutical manufacturing company. The private company is based in San Diego, CA. | Pharmaceuticals: Major | General Counsel | |
TELIX PHARMACEUTICALS LIMITED | Biotechnology | General Counsel | |
Clinical Data Interchange Standards Consortium, Inc.
![]() Clinical Data Interchange Standards Consortium, Inc. Miscellaneous Commercial ServicesCommercial Services Clinical Data Interchange Standards Consortium, Inc. is a non-profit organization that creates clarity in clinical research by developing and advancing data standards of the highest quality. CDISC standards are required by the United States Food and Drug Administration (FDA) and Japan's Pharmaceuticals and Medical Devices Agency (PMDA), recommended by the China National Medical Products Administration (NMPA), and adopted by the world's leading research organizations. These standards enable the accessibility, interoperability, and reusability of data, maximizing the value of data for more efficient and meaningful research that has invaluable impact on health. CDISC actively collaborates with Europe's Innovative Medicines Initiative and is strategically positioned as a standards governance body that supports and maintains standards not only for clinical research but also for public health. The American company was founded by Rebecca Daniels Kush and David A. Evans has been the CEO of the company since 2021. | Miscellaneous Commercial Services | Director/Board Member | |
University of Delaware | College/University | Doctorate Degree | |
Franklin & Marshall College | College/University | Undergraduate Degree | |
Venatorx Pharmaceuticals, Inc.
![]() Venatorx Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Venatorx Pharmaceuticals, Inc. develops novel anti-infective agents to address the threat of antibiotic resistance. It offers antibiotic resistant bacteria and Carbapenem-resistant Enterobacteriaceae a family of gram-negative bacteria that are resistant to all known ?-lactam antibiotics, including penicillins, cephalosporins, monobactams, and carbapenems. The company was founded by Christopher J. Burns, Luigi Xerri, and Daniel Pevear in 2010 and is headquartered in Malvern, PA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
VTV THERAPEUTICS INC. | Pharmaceuticals: Major | Director/Board Member | |
The Johns Hopkins University | College/University | Doctorate Degree | |
Istari Oncology, Inc.
![]() Istari Oncology, Inc. BiotechnologyHealth Technology Istari Oncology, Inc. operates as a clinical-stage biotechnology company. It focuses on novel immuno-oncology and immunotherapy platforms for the treatment of glioblastoma and a wide variety of tumors. Its core technology assets are PVS-RIPO, a prototypic oncolytic recombinant polio virus vaccine, and a series of antibody-drug conjugates comprising antibodies or antibody fragments to a variety of oncology targets. The company was founded by Darell D. Bigner and Matthias Gromeier in 2016 and is headquartered in Research Triangle Park, NC. | Biotechnology | Director/Board Member | |
TALIS BIOMEDICAL CORPORATION | Medical Specialties | Director/Board Member | |
Berkeley University of California | College/University | Masters Business Admin | |
BIOGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal |
Statistics
International
United States | 47 |
France | 3 |
Netherlands | 2 |
Australia | 2 |
Sectoral
Health Technology | 32 |
Consumer Services | 13 |
Commercial Services | 5 |
Finance | 2 |
Industrial Services | 2 |
Operational
Director/Board Member | 57 |
Corporate Officer/Principal | 41 |
Independent Dir/Board Member | 17 |
Undergraduate Degree | 14 |
President | 9 |
Most connected contacts
Insiders | |
---|---|
Julian Baker | 20 |
David Milligan | 16 |
William Sibold | 14 |
Marc R. Schneebaum | 13 |
James Daly | 13 |
Keith Gollust | 12 |
Alex Howarth | 11 |
Kianoush Motesharei | 10 |
Raymond Cheong | 6 |
Remy Sukhija | 6 |
Tina Ventura | 6 |
Mark Barrett | 5 |
Robert Waltermire | 4 |
Ronald Filippo | 4 |
Dominic F. Labriola | 3 |
- Stock Market
- Insiders
- Brian Lynch
- Company connections